Navigation Links
DOTS For Tuberculosis TO Cover Entire Country

The Directly Observed Treatment Short-course (DOTS) tuberculosis control programme will cover the entire country by November 2006 said union Health Minister Anbumani Ramadoss said here Sunday.//

"The drugs for the DOTS programme will be made available even in petty shops and dhabas in remote areas," said the minister at a function here to open a new HIV vaccine trial and patient care facility.

The facility has come up at the Tuberculosis Research Centre (TRC) here at a cost of Rs.112.5 million.

The TRC, an institution under the umbrella of the Indian Council of Medical Research, was set up in 1956 and is marking its golden jubilee this year.

Source: IANS
'"/>




Page: 1

Related medicine news :

1. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
2. Defending against Tuberculosis
3. Easier Tests To Detect Tuberculosis
4. Smoking Increases The Risk Of Developing Tuberculosis Infection
5. Gene Target For Tuberculosis Identified
6. WHO declares Tuberculosis – ‘An Emergency’ in Afrca
7. New Vaccine Targeted At Effective Treatment Against Tuberculosis
8. Time for A.R.Rahman to rock the Tuberculosis Awareness Programme
9. BCG vaccine for both Protection and treatment of Tuberculosis
10. Diagnostic Procedure For Tuberculosis Made Easy
11. PA-824 drug effective against Tuberculosis

Post Your Comments:
(Date:12/3/2009)...3 Three US Oncology, Inc . busine...ward in the Occupational Safety & Health categ...ption in 2005, US Oncology Specialty, LP ; US Onc...n center; and OncologyRx Care Advantage(TM ) oral...Occupational Excellence Award from the national or...
(Date:12/3/2009)... professionals specialising in solid organ transpl...them through the complex clinical issues posed by ...er, published online by the American Journal of T...the significant concerns that swine flu could comb...(H5N1), to develop into a strain with unpredictabl...
(Date:12/3/2009)... teens reduce differences in incidence, deaths, re...hDay News) -- Efforts to prevent teens from smokin...cancer incidence and death rates among adults in t...uses most lung cancer cases in the United States. ... blacks than in whites at all ages. Since the 1970...
(Date:12/3/2009)...rthritis Foundation bestowed its highest nationwid...s national meeting in Atlanta. , ...Foundation bestowed its highest nationwide honors ...l meeting on Nov. 20 in Atlanta. The honorees are...tinguished Service ,The Arthritis Foundation honor...
(Date:12/3/2009)... Kessock receives President’s Service Award....mber 2, 2009 -- CS3 Technology, a leading professi...ons to businesses across the country, is pleased t...year at their company-wide retreat, CS3 recognizes...his year, Cindi Kessock earned the President&rsquo...
Breaking Medicine News(10 mins):Health News:US Oncology Celebrates Consecutive Safety 2Health News:US Oncology Celebrates Consecutive Safety 3Health News:Transplant infectious disease experts provide pandemic guidance 2Health News:Transplant infectious disease experts provide pandemic guidance 3Health News:Lung Cancer's Racial Gap Narrowing 2Health News:Arthritis Foundation Bestows Highest National Awards 2Health News:Arthritis Foundation Bestows Highest National Awards 3Health News:Arthritis Foundation Bestows Highest National Awards 4Health News:CS3 Technology Announces Annual Employee Awards 2Health News:CS3 Technology Announces Annual Employee Awards 3
...hat Mylan Pharmaceuticals Inc. has received final ...n (FDA) for its supplemental Abbreviated New Drug...0 mg. Fluoxetine Capsules are the generic ... 31, 2007, for the 40 mg strength. This produ...
...s of the peripheral nervous system that is most re... The finding, reported on-line in the journal...hanisms by which the body detects temperature sens...se pain. As such, the receptor known as m...
...ts at the University of Wisconsin-Madison have ide... infect their hosts . The researchers iden...ommon parasite Toxoplasma gondii, prevented the pa...ugs that could block or treat human parasitic infe...
...te simulations we can see there are changes in fea...ural variability',said CSIRO oceanographer Dr Gael... certainly linked to changes in the heat structure...ime, we are seeing changes in ocean circulation in...
...r multinational corporations to take control of th...ists in US charge. With sales of over $35 billion ...ns are doing whatever it takes to buy up pristine ...0 different brand names -- such as Arrowhead, Cali...
... California has got in touch with the Beverly Hill...e Lindsay Lohan was served alcohol before a weeke...oholic Beverage Control investigators also want to... am, an hour-and-a-half after closing time. ...
Other Medicine News:Health News:Detecting Cold, Feeling Pain: Study Reveals Why Menthol Fresh 2Health News:Detecting Cold, Feeling Pain: Study Reveals Why Menthol Fresh 3Health News:Mutant Parasites, Unable to Infect Hosts, Highlight Virulence Genes 2Health News:Climate Change Signal Detected in the Indian Ocean 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 3Health News:Multinationals Exploit Groundwater Sources, and People Suffer 4Health News:Multinationals Exploit Groundwater Sources, and People Suffer 5
(Date:12/2/2009)...ALTO, Calif., Dec. 2 Var...ber 25, 2009, Varian, Inc. filed with the U.S. Sec...on Form 10-K for the fiscal year ended October 2, ...the Company,s web site at www.varianinc.com, by cl...on "10-K" in the table shown. Stockholders may re...
(Date:12/2/2009)...NEW YORK, Dec. 2 Reportlinker.com ...ilable in its catalogue: ,, Chiral Technology ..., http://www.reportlinker.com/p0164212/Chiral-T...s.html ,, The fast developing small molecule ... activity with pharmaceutical companies adding chi...
(Date:12/2/2009)...EW YORK, Dec. 2 Reportlinker.com a...lable in its catalogue: ,, Multiple Myeloma T..., http://www.reportlinker.com/p0164271/Multiple....html ,, Given the severity, and relentless re...nt therapies and treatments to battle the disease ...
Breaking Medicine Technology:Reportlinker Adds Chiral Technology - International Technology & Market Trends 2Reportlinker Adds Chiral Technology - International Technology & Market Trends 3Reportlinker Adds Chiral Technology - International Technology & Market Trends 4Reportlinker Adds Chiral Technology - International Technology & Market Trends 5Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 2Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 3Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 4Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 5Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 6Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 1Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 2Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 3Screen All Newborns for Hip Dysplasia Study Urges 51115 1Screen All Newborns for Hip Dysplasia Study Urges 51115 2Experts Keep Wary Eye on Tamiflu Resistant Swine Flu 51113 1Experts Keep Wary Eye on Tamiflu Resistant Swine Flu 51113 2Experts Keep Wary Eye on Tamiflu Resistant Swine Flu 51113 3
...atients May Be Amenable to Chaperone ...13 Amicus Therapeutics, a,biopharmaceutical compa...pharmacological chaperones for the treatment of hu...any will present positive results from an ex,vivo ... (1-deoxynojirimycin,HCl), Amicus, compound in dev...
...ch 13 Raven,biotechnologies, inc., a privately he...t of monoclonal antibody therapeutics (MAbs) for c...e 2 study of RAV12, its lead,clinical product, in ...atients with metastatic pancreatic cancer., The P...t approximately,20 institutions in the US. The fir...
Other Medicine Technology:Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 2Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 3Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 4Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 2Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 3
MicroFinger Irrigating Nucleus Chopper
Dodick-Kammann Nucleus Chopper
Langerman Phaco Chopper
Minardi Phaco Chopper
Medicine Products: